Company
Headquarters: Verdellino, BG, Italy
Employees: 607
CEO: Mr. Marco Francesco Eigenmann
€223.8 Million
EUR as of July 1, 2024
US$240.3 Million
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
Fine Foods & Pharmaceuticals N.T.M. S.p.A. engages in the contract development and manufacturing of oral solid forms for the pharmaceutical and nutraceutical industries. Its pharmaceutical products include powders and granules, tablets, film-coated tablets, and hard gelatine capsules; and nutraceutical products comprise soluble and effervescent powders and granules, soluble, effervescent and chewable tablets, film-coated tablets, and hard gelatin capsules. The company also develops and manufactures medical devices for gastrointestinal treatment, oral and throat treatment, and weight management. Fine Foods & Pharmaceuticals N.T.M. S.p.A. was founded in 1984 and is based in Verdellino, Italy.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Fine Foods & Pharmaceuticals N.T.M. S.p.A. has the following listings and related stock indices.
Stock: MTA: FF wb_incandescent